Investment Stage

Focus Areas

About Investor

Kenneth Harrison serves as a Senior Partner at Novo Ventures, investing across medical devices, pharmaceuticals, biotech, health services, health IT, diagnostics, and digital health from pre-seed through Series B stages, with investment ranges typically between $100K and $5.0M. Ken brings experience from his previous role as Senior Market Planning Manager at Genentech, where he guided strategic decision-making for Ophthalmology and HER2 franchises. He also worked as a management consultant at L.E.K. Consulting and as Entrepreneurship Program Manager at QB3/Mission Bay Capital, and holds a PhD in Pharmacology from Yale University.